IMAX (IMAX) Q4 2025 Earnings Call Transcript

IMAX reported a record 2025 with global box office of $1.28 billion, up 40% year over year, revenue of $410 million (+16%), adjusted EBITDA of $185 million (+33%), and adjusted EPS of $1.45, while margin expanded to 45%. The company also posted record operating cash flow of $127 million, ended with $151 million in cash and 0.7x net leverage, and outlined 2026 guidance for 160-175 installations and a 45%+ EBITDA margin floor. Management struck an upbeat tone on a strong 2026–2028 slate, local-language growth, and capital deployment into network expansion and dilution reduction.

Analysis

IMAX is transitioning from a cyclical content-leverage story into a quasi-infrastructure compounder: the key isn’t just higher box office, it’s that utilization is now pulling forward both install demand and pricing power at the exhibitor level. That creates a second-order loop where strong PSAs make new screens and second-location builds easier to finance, which in turn expands the addressable network and increases IMAX’s bargaining power on future deal structures. The balance sheet is now being used as an accelerator, not a defensive cushion, which should compress the market’s historical multiple discount for earnings volatility.

The market may be underestimating how much of 2026-2028 is already de-risked by the booked slate and the company’s unusually visible funnel of filmmaker relationships. The more important edge is not headline tentpoles, but the repetition of creator advocacy and format-specific production decisions, which makes IMAX less dependent on any one title and more embedded in the marketing ecosystem. That should support a higher-quality revenue mix, with local-language, alternative content, and live events acting as volatility dampeners rather than side bets.

The main bear case is timing, not thesis: if China or a couple of marquee titles slip, near-term expectations could be pushed into 2H26, creating an air pocket for the stock despite unchanged 2-3 year economics. Another risk is capital allocation creep; using balance sheet firepower for faster installs is attractive only if paybacks stay within a tight hurdle, otherwise the market will re-rate it as growth spending with weaker optionality. The contrarian read is that the stock may still be too cheap if investors are anchoring to a movie-exhibitor multiple instead of a branded network with scalable operating leverage and limited capex intensity.

Key Decisions for Investors

• Go long IMAX on any post-earnings pullback over the next 1-3 weeks; use $1.5B+ 2026 box office visibility and install acceleration as the catalyst for a multiple re-rating toward a premium-media/network peer set.
• Pair trade: long IMAX / short CNK for 3-6 months. IMAX has cleaner operating leverage, better balance-sheet flexibility, and less exposure to generic attendance cyclicality; the short leg hedges any sectorwide box office disappointment.
• Buy IMAX Jan-2027 call spreads if implied volatility compresses after the call. The setup is a multi-year margin expansion story with limited downside from de-levered capital structure, while upside is tied to slate execution and second-screen rollout.
• Consider AAPL as a small secondary long only as an event-content optionality trade. The F1/IMAX partnership is not material to AAPL fundamentals, but it adds low-cost marketing reach and live-event experimentation that can expand IMAX’s non-film mix.
• Avoid chasing after a strong quarter; wait for any Q1/Q2 weakness tied to timing noise in China or release slippage. The best risk/reward entry is a 5-10% drawdown that is not accompanied by guidance cuts.